Verona Pharma Initiates Phase 3 Clinical Trials with Nebulized Ensifentrine for the Maintenance Treatment of COPD
Share Talk Bulletin Board Heroes, Friday 14th August 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Weekly Stock Market News, 19th July 2020
Share Talk highlighted nine, yes nine new company “52-wk high” across our social media platforms, who said private/retail investors do not like the small micro-cap space.
Verona Pharma plc (VRP.L) $200 Million in Oversubscribed Private Placement and Subscription
Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces it has raised approximately $200 million (£159 million*).
Share Talk Bulletin Board Heroes, Tuesday 31st March 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Share Talk Weekly Stock Market News, 19th January 2020
25th April 2020 UK Investor Show an all-star line-up,100 free tickets available! For 100 lucky Share Talk readers on a first-come-first-served basis. (link to www.ukinvestorshow.com/tickets ) using promo code ShareTalk2020.
Share Talk Bulletin Board Heroes, Tuesday 7th January 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update.
Share Talk Bulletin Board Heroes, Monday, 5th August 2019
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update.
Verona Pharma plc (LON:VRP) Announces Departure of Chief Medical Officer
LONDON, April 11, 2018 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma” or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory
Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) Provides Clinical Development Update
Verona Pharma Provides Clinical Development Update Accelerates top-line data readouts from ongoing clinical trials with RPL554 in COPD and CF LONDON, Feb. 13, 2018 (GLOBE NEWSWIRE) — Verona Pharma plc